International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 416

PDF Downloaded: 237


Get Permission Sharma and Sharma: Biochemical evaluation of depigmentation in C57/BL6 mice and its treatment by Psoralea corylifolia. Linn (Bakuchi) seed oil and seed extracts


Introduction

Vitiligo is an acquired, idiopathic, hypomelanotic disease characterized by circumscribed depigmented macules (Ontonne J P and Bose S K., 1993)1 vitiligo is a disorder of pigmentation where the loss of functional melanocytes takes place. Vitiligo affects 1% of the population. According to recently updated literature prevalence of vitiligo persists from 0.5 -2% of the total world population (Bergqvist C and Ezzedine K., 2020).2 This problem is best emphasized by the terminology used in southern India as ven kushtham, meaning white leprosy (Gupta et al., 2012).3

Clinical presentation includes vitiligo, characterized by a lesion that occurs in a) dermatomal, asymmetric distribution of limited clinical significance b) focal vitiligo, characterized by a limited number of small lesions c) generalized vitiligo, the most common type of vitiligo. Where lesions occur in bilateral symmetrical distribution and d) universal vitiligo, complete or almost complete depigmentation (Gupta et al., 2012; Boisseau- Garsuad et al., 2002).4 

16-35% of patients with vitiligo experience psychiatric morbidity. Depression 10%, dysthymia (17-19%), sleep disturbance (20%), suicidal thoughts (10%), suicidal attempts (3.3%), and anxiety (3.3%) have been found in those affected with vitiligo. It can also lead to difficulties in forming a relationship, avoidance of certain social situations, and difficulties in sexual relationships (Porter J et al.,1990; Ongenae K et al., 2003).4 Vitiligo affects the patients psychologically which is well recognized (Elbuluk and Ezzedeni., 2017).5 Because appearance is quite important in the present day to day life, and easily visible skin disorder affects the mental status and daily life of the patient pushing the patient towards the daily stigma which results in mental disorder (Wu and Cohen., 2019).6 There are three main hypotheses for the pathogenesis of vitiligo: self-destruction, neural and autoimmune.

Biochemical basis of vitiligo

Melanocytes are melanin-producing cells found in the skin. Melanocytes are highly dendritic and these dendrites project into the Malpighian layer of the epidermis where they transfer the melanosomes to approximately 36 keratinocytes in the neighborhood and this entire unit is called the epidermal melanin unit (Shahjil et al.,2006). Apart from skin, melanocytes are present in retinal pigment epithelium, uveal tract, inner ear, and leptomeninges. In they reside in the matrix of the hair follicle of the basal layer of the epidermis. Tyrosinase is a key enzyme required for melanin synthesis. Tyrosinase catalyzes the hydroxylation of tyrosine to dihydroxyphenylalanine (DOPA), which is the rate-limiting step of melanin synthesis (Hearing VJ.,1999).7 DOPA undergoes oxidation of dopaquinone, which is immediately converted to DOPAchrome and then to 5,6 dihydroxy indole (DHI). TRP2 (tyrosine-related protein 2) converts dopachrome to dihydroxyindole carboxylic acid (DHICA). DHI and DHICA further polymerize to form eumelanin. Cystine/ glutathione reacts with dopaquinone to produce cysteinyldopas that undergo further cyclization to benzothiazines and higher condensates give rise to confer photoprotection to the skin from ionization radiations (Hearing V.J., 1999).7 Keratinocytes are the cell where the storage of melanin takes place. Human keratinocytes are the cells that make up the majority of the epidermis and express only beta 2 adrenergic receptors. The beta-adrenergic receptor is a seven-pass trans-membrane G protein-linked coupled receptor. A beta 2 AR expression is more highly expressed at the basal layer of the epidermis and decreases in expression toward the stratum corneum. Both keratinocytes and melanocytes express beta 2 AR, and keratinocytes have been demonstrated to generate norepinephrine. Stimulation of the beta 2 AR on melanocytes increases the intracellular level of cAMP and subsequently increases melanogenesis. Normal epidermal keratinocytes can endogenously generate epinephrine, they may be provided local stimulation of this beta 2 AR-mediated pathway for melanogenesis in the normal melanocytes.

Psoralen the active component of Psoralea corylifolia Linn. is recommended by clinicians, but the mode of action inside the body is exactly not known. It's not a permanent treatment. During the therapy, the patient is exposed to UVA and UVB light for at least half an hour. This causes heavy inflammation, pain, and sores on the exposed skin. UVA and UVB exposure can also cause melanoma. It is not justified ethically, to cure a disease-causing another disease. This treatment is not a reliable treatment and time taking. And the patient has to suffer more and more stress and social trauma, because of disturbed family and social life. The seeds are more effective than the psoralen (active component). Other chemical components of Psoralea corylifolia Linn. having potent antioxidant potential, will also be studied to get better results. The objectives of the present study were comparative evaluation of different doses of different extracts of Psoralea corylifolia seed and seed oil in the model system Rattus rattus species C57/BL6 through the biochemical study of different pigment makers. To study the rate of regeneration of the apoptotic melanocytes in the skin by increasing the antioxidant potential and avoiding the inhibition of tyrosinase the rate-limiting enzyme of melanogenesis. To establish the drug and its doses for the treatment of vitiligo. To study the changes occurring in depigmented skin by histopathology and recovery via Psoralea corylifolia seed and seed oil administration.

Hypothesis

  1. Psoralen in the active component of Psoraliya corylifolia Linn. seeds, it is applied topically on the affected area, under the UV exposure for minimum 15 minutes, which results in trauma, pain, inflammation and psores in the patients. The treatment also revert after therapy completion. The present study is designed by providing the seed extract of Psoralia corylifolia Linn. with seed powder orally and seed oil topically without any UV exposure only in the presence of sunlight. No psores, inflammation or uneasiness was observed in the study samples, due to increased anti- oxidant potential.

  2. Increased anti- oxidant potential played a major role in regeneration of melanocytes.

Materials and Methods

The study was carried out in the Department of Biochemistry in collaboration with the Department of Pharmacology, G. R. Medical College, Gwalior (M.P). The approval of the ethical committee has been taken for this research work. The herbal sample (seeds) of Psolarea corylifolia. Linn has been collected from Lalitpur district. U.P and the samples were authenticated by Ayurvedic Research Centre, Gwalior (M.P).

C57/BL6 strain of mice was selected for the present study. The mice were purchased from National Centre for Laboratory Animal and Science (NCLAS), Hyderabad. Ten mice were purchased and further breeding was carried out under lab conditions. 12/12 hrs day-night cycle, with water from Ad Labitum and protein-rich food pallets, were provided. Complete care of echogenicity was taken. SOD, MDA, GSH, GPx, vitamin E, and uric acid were estimated in skin punch lysate. In the acute study control group and two toxicant groups were taken. The control group has non-vitiligo mice, while toxicants a and b have 5%gm w/v TBC and 10%gm w/v TBC topically. In subchronic study 100 mg/kg b.w, 200 mg/kg b.w and 300 mg/kg b.w ethanolic extract and petroleum ether extracts of Psoralea corylifolia seeds given orally.

Results

A total of 78 mice were taken for the study. In the control group, healthy or non-vitiligo mice were studied. Animals were divided into 13 groups of 6 mice each. The toxicant groups were studied to gain the best toxicant. 5% gm w/v TBC in acetone has further proceeded for the study. Significant change of study parameters in drug-treated groups (group 4to group 9), by 6 different doses of ethanolic and petroleum ether extract 100 mg/kg b.w, 200 mg/kg b.w, and 300 mg/kg b.w. 100 mg/kg b.w of petroleum ether extract showed a significant increment in SOD (P<0.01**) and a less significant increment in vitamin E (P<0.05*). But no significant changes were found in the level of MDA, GSH, GPx, and uric acid (Table 2 ).

Significant changes were seen in the study parameters in drug-treated groups topically by seed oil for 3 weeks, 5 weeks, and 7 weeks. Group treated topically by seed oil of P. corylifolia  for 5 weeks, showed significant lowering (P<0.01**) in SOD level in comparison to toxicant a group and less significant increment.

(P<0.05*) in vitamin E level. Highly significant (P<0.01**) increment was seen in GPx level in 5 weeks seed oil treatment group. No significant change in the level of MDA, GSH, and uric acid (Table 3)

Table 1

Study parameters of SOD, MDA, GSH, GPx, vitamin E and uric acid

S. No

Group 1 (n= 6)

Group 2 (n= 6)

Group 3 (n= 6)

SOD (U/ ml)

969.15±388.56

2840±201.60

2515±156.27**

MDA (mole/gm/min)

151±13.01

210±13.26

205±29.27

GSH (mg/dl)

40.41±0.12

24.25±0.96

24.25±1.09

GPx (µmole GSH utilized)

54.00±1.20

13.23±1.23

15.52±1.17

Vitamin E (IU/ mole plasma)

15.00± 1.04

8.00±1.40*

8.82±1.90

Uric acid (mg/dl)

4.56± 1.07

3.34±1.80

2.26±1.09

The Table 1 shows levels of SOD, MDA, GSH, GPx, Vitamin E and Uric acid in group 1 to group 3, each having 6 animals.

Table 2

Showing study parameters in group 4 to 9

S. No

Group 4

Group 5

Group 6

Group 7

Group 8

Group 9

SOD(U/ml)

1015.09±376.09

1019.12±375.10

1126.12± 380.12

1012.12±275.08

1026.14±371.12

1221.12±360.12**

MDA (mole/gm)

225.01±21.10

220±22.07

225.12±21.08

221.02±21.10

220±20.12

210±20.14

GSH (mg/dl)

42.26±1.14

39.24±1.804

40.25±1.04

46.02±1.14

46.02±1.18

46.01±1.14

GPx (µ mole/GSH utilized)

41.02±1.39

40.09±1.17

45.10±1.18

45.03±1.16

48.04±0.98

44.0±1.18

Vit E (IU/ mole hom)

11.03±1.50

12.06±1.68

14.07±1.66

12.05±1.68

12.07±1.61

11.08±1.60

Uric acid (mg/dl)

4.16±1.12

5.01±1.25

5.03±1.24

5.12±1.36

5.16±1.67

5.17±1.68

Table 2 showing levels of SOD, MDA, GSH, GPx, Vitamin E and Uric acid in group 7 to group 12, each having 6 animals.

Table 3

Showing study parameters of group 10, group 11, group 12

S. No   

Grp 10

Grp 11

Grp 12

SOD (U/ ml)

978.10±310.11**

1012.12±375.10

1014.13±270.09**

MDA (mole/gm)

210±20.14

221.08±22.09

220.10±21.07

GSH (mg/dl)

42.20±1.09

45.10±1.20

46.02±1.09

GPx (µ mole/GSH utilized)

73.01±0.82*

40.22±1.08

42.91±1.10

Vit E (IU/ mole plasma)

10.11±1.2

12.08±1.70*

14.07±1.8

Uric acid (mg/dl)

3.92±1.25

5.05±1.06

6.17±1.40

The Table 3 shows levels of SOD, MDA, GSH, GPx, Vitamin E and Uric acid in group 10 to group 12, each having 6 animals.

Table 4

Study showing parameters of group 1, group 2, group 7 and group 13

S. No

Group 1     (n= 6)

Group 2 (n= 6)

Group7

Group 13

SOD (U/ ml)

969.15±388.56

2840±201.60

1012.12±275.08

1002.11±215

MDA (mole/gm/min)

151±13.01

210±13.26

221.02±21.10

188.01±09.8*

GSH (mg/dl)

40.41±0.12

24.25±0.96

46.02±1.14

42.04±0.22**

GPx (µmole GSH utilized)

54.00±1.20

13.23±1.23

45.03±1.16

49.09±9.02

Vitamin E (IU/ mole plasma)

15.00± 1.04

8.00±1.40*

12.05±1.68

12.11±2.01

Uric acid (mg/dl)

4.56± 1.07

3.34±1.80

5.12±1.36

4.01±0.07

The Table 4 shows levels of SOD, MDA, GSH, GPx, Vitamin E and Uric acid in group 1, group 2, group 7 and group 13, each having 6 animals.

Figure 1

Showing graph of SOD and MDA in groups 1 to 3

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5fc66d20-f18b-4c76-900c-089a0d54dde4image2.png

Figure 2

Showing graph of GSH, GPx, Vitamin E and uric acid in groups 1 to 3

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/6acb3472-200e-479e-b2d8-b4cd7a45bde3/image/f6424641-e1ad-420c-8442-0a6d3ae0359d-uimage.png

Figure 3

Showing graphs of SOD and MDA in groups 4 to 9

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5fc66d20-f18b-4c76-900c-089a0d54dde4image3.png

Figure 4

Showing graph of GSH, GPx, vitamin E and uric acid in groups 4 to 9

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5fc66d20-f18b-4c76-900c-089a0d54dde4image4.png

Figure 5

Showing graph of SOD and MDA in groups 10 tp 12

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5fc66d20-f18b-4c76-900c-089a0d54dde4image5.png

Figure 6

Showing graph of GSH, GPx, vitamin E and uric acid in groups 10 to 12

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5fc66d20-f18b-4c76-900c-089a0d54dde4image6.png

Figure 7

Showing graphs of SOD, MDA in groups 1, 2, 7 and 13

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5fc66d20-f18b-4c76-900c-089a0d54dde4image7.png

Figure 8

Showing graphs of GSH, GPx, vitamin E and Uric acid

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5fc66d20-f18b-4c76-900c-089a0d54dde4image8.png

Discussion

Hypomelanosis is referred to as the decreased level of melanin in the epidermis, which results in two different kinds of changes (a) Decreased number or absence of melanocytes in the epidermis results in little or no melanin production (melanocytopenic hypomelanosis) e.g. vitiligo and (b) No decrease in the number of melanocytes but decreased melanin production. During the senescence process, the density of melanocytes in the skin decreases physiologically near about 10% per decade (Gilchrest., 1979)8 but the loss of pigmentation can occur at any stage after exposure to myelotoxic agents.

Hypomelanosis can occur post-inflammatory and results from increased keratinocytes turnover that interferes with the melanosomal transfer as well as the activation of inhibitory cytokines. Neurochemical mediators such as norepinephrine and acetylcholine are toxic to melanocytes. Studies on vitiligo patients showed a higher level of plasma, urine catecholamine, and their metabolites, especially at the onset of the disorder (Cuchi et al., 2003).9 A high concentration of norepinephrine and its metabolites may be due to a reduction in phenylethanolamine – N-methyl transferase (PNMT) activity and an increase in tyrosine hydroxylase (TH) activity. These enzymes convert L-tyrosine to L-dopa. Defective recycling of 6BH4 lead to the increased non-enzymatic production of 7BH4, concomitant with increased production of H2O2. The presence of 7BH4 in the epidermis initiates the process of depigmentation in vitiligo patients by blocking the L-Tyrosine supply to melanocytes. These alterations cause melanocyte destruction in vitiligo (Schalleuter et al., 1994).10

Tyrosinase is a key enzyme required for melanin synthesis. Tyrosinase catalyzes the hydroxylation of tyrosine to dihydroxyphenylalanine (DOPA), which is the rate-limiting step of melanin synthesis (Hearing VJ., 1999).7 DOPA undergoes oxidation of dopaquinone, which is immediately converted to DOPAchrome and then to 5,6 di-hydroxy indole (DHI). Tyrosine-related protein (TRP2) converts dopachrome to dihydroxyindole carboxylic acid (DHICA). DHI and DHICA further polymerize to form eumelanin. Cystine/ glutathione reacts with dopaquinone to produce cysteinyldopas that undergo further cyclization to benzothiazines and higher condensates give rise to photoprotection to the skin from ionization radiations (Krishnamurthy., 1969).11

It is not just a dermatological problem. It is a disorder of melanocytes. Melanocytes arise from the neural crest in embryonic life. The embryonic ectoderm also originates from the margins of the neural plate which forms the tubular central nervous system. 

In the present study, we selected the plant Babchi belongs to the family Fabaceae described under the botanical name Psoralea corylifolia, described as Kalamashim in Sanskrit. Psoralea corylifolia Linn. is an annual herb growing throughout India. The plant is of immense biological importance and it has been widely exploited for ages, for its magical effect against several skin diseases like psoriasis, leucoderma, and leprosy. It is reported to contain essential oils, coumarins, alkaloids, flavonoids, and terpenoids (Krishnamurthy., 1969),11 Ayurvedic Pharmacopoeia of India (1989). The active compound of Psoralea corylifolia Linn. is a psoralen.

Psoralen has been found to intercalate into DNA, where they form mono and di-adduct in the presence of long-wavelength UV light and thus are used for the treatment of hypopigmented lesions of the skin, like leucoderma (Vaidya., 2006).12 The studied plant Psoralea corylifolia Linn. also contains oils, coumarins, alkaloids, flavonoids, and terpenoids. Major active components were bakuchiol, bakuchiol, psoralen, 7- methoxy bavachin, psoralester, and psorachrome 2.

In this study, we applied toxicant TBC (tertiary butyl catechol) 5% and 10% w/v in acetone, topically on shaved area of mice skin, which causes oxidative stress. Due to an increase in oxidative stress, the level of SOD increased in both groups (groups 2 and 3) in comparison to control. 

Oxidative stress arises, and ROS are generated. The ROS non-competitively bind to the meta-phenolic position of tyrosinase, on meta-position electron density, decreases, and the structure of tyrosinase disintegrates. Groups 4 to 9 showed increased SOD levels. In groups, 10, 11, and 12 Psoralea corylifolia Linn seed oil was applied topically for 3 weeks, 5 weeks, and 7 weeks respectively. Group 12 showed a lowering in increased SOD levels in comparison to control. This group contains Psoralea corylifoia Linn. seed oil topically applied for 5 weeks. Group 12 was selected for further studies. Group 7 showed better results in comparison to the control and was combined studied with group 11 and better results were gained. This reveals that there is an imbalance in the oxidant-antioxidant system. Oxidative stress due to disease activity results in a high level of superoxide dismutase (SOD).

In vitiligo patients, the epidermal levels of ubiquinol vitamin E, reduced glutathione (GSH). An imbalance of the intracellular redox status and a significant depletion of enzymatic and non-enzymatic antioxidants are seen in the epidermis of vitiligo patients and represent the figure print of abnormal oxidative stress leading to epidermal cell injury (Passi et al., 1998).13 A decreased GSH is associated with a strong decrease in tyrosine hydroxylase activity and melanin production in the skin (Bentham et al., 1999).14 In groups 2 and 3 (toxicant groups) level of GSH decreases considerably and lead to the appearance of hypopigmentation in shaved area of mice. While therapeutic groups are showing an increase in GSH levels. 

Alpha-tocopherol deficiency authenticates the susceptibility of the cell to oxidative membrane injury (Goth J., 2004)15 which results in epidermal oxidative stress and may cause premature melanocyte death. In groups 2 and 3 levels of Vitamin E are decreased as compared to control, this promotes oxidative membrane injury. This decreased level of alpha-tocopherol was increased in group 7, group 11, and group 13. Whereas group 12 showed a relatively increased level of Vitamin E, so not chosen as good doses against vitiligo.

Reactive oxygen species (ROS) are capable of bleaching constitutional melanin and causing membrane lysis through lipid peroxidation reactions. The level of MDA was increased intoxicant group as compared to the control. Only group 11 showed a lowering in the level of MDA and all the other groups showed higher values of MDA, but not more significant than SOD and Vitamin E. Increased values of MDA cause membrane lysis, and the lowered values gained in two groups 11, helped to conclude better doses due to less cell membrane injury. As the cell membrane is less injured, the regeneration of melanocytes takes place and repigmentation appears.

Uricase convert uric acid to allantoin and H2O2. This H2O2 causes cell membrane injury and leads to melanocyte death. The level of uric acid decreases intoxicant group as compared to the control. Only group 11 showed an elevated level of uric acid as compared to toxicant groups 2 and 3. Group 12 showed more increase, but not significant, in the value of uric acid as compared to the control.

The impaired redox status theory states that in vitiligo melanocytes death results from an intrinsic increased sensitivity to oxidative stress that arises either from toxic intermediates of melanin precursors or from other sources (Njoo et al., 1998).16 Low GPx activity leads to epidermal accumulation of H2O2 has been demonstrated in lesional and non-lesional skin (Gilchrest., 1979).8 In toxicant groups 2 and 3 levels of GPx were decreased. The level of GPx was increased near normal in groups 11 and 13. Rest groups were not showing any significant change in GPx level as compared to the control. 

Death of melanocytes is not essential for depigmentation in vitiligo but speculates either a primary effect on inhibition of melanogenesis or on the disappearance of melanocytes because of defective adhesion (Mosher et al., 1993).17 First, the presence of residual melanocytes in the follicular reservoir gives rise to the repigmentation of vitiliginous patches after phototherapy. Persistent melanocytes, which showed an ectopic distribution of pre-melanosomes within keratinocytes of the suprabasal layers, have been observed in lesional skin of long-standing vitiligo (Alkoy M et al., 2002).18

It has been proposed that vitiligo is a sequential two-stage disorder (Alkoy M et al., 2002.18 In the first stage, tyrosinase activity decrease while in the second stage inhibition of melanization induces the death of melanocytes (Njoo et al., 1998).16 An increased level of tension has been detected in the basal membraneand papillary dermis (Schalleuter et al., 1994)10 suggesting that this extracellular matrix molecule inhibits the adhesion of melanocytes to fibronectin and thus might contribute to the loss of melanocytes in the vitiligo.

Conclusion

A present study was carried out to find antioxidant levels in depigmented skin samples and its neutralization by Psoraleya corylifolia Linn. therapy. An imbalance in the antioxidant system and free radical-mediated damage are initial pathogenic events in melanocyte degeneration in vitiligo.

The study was carried out on 78 C57/B6 mice. They were divided into control, toxicant a, toxicant b, ethanolic extract 100 mg/ kg b.w, 200 mg/kg b.w, 300 mg/kg b.w, petroleum ether extract 100 mg/ kg b.w, 200 mg/kg b.w, 300 mg/kg b.w orally, seed oil topically applied for 3 weeks, 5 weeks and 7 weeks and prophylactic study divided into 3 groups to check the best combination of oral and topical therapy best dose of aqueous extract 200 mg/kg b.w and seed oil topically applied for 3 weeks, 5 weeks and 7 weeks, having 6 animals each.

Where 100 mg/kg b.w of petroleum ether showed better results for SOD and MDA, while for GSH and vitamin E ethanolic extract 300 mg/kg b.w showed better results in comparison to the earlier one.

Due to the appearance of several adverse effects and increasing withdrawal of the patients from existing treatment nowadays, we designed this study, by concentrating on the antioxidant free radical scavenging concept, to minimize the adverse effect of existing therapy. The existing therapy includes 15 to 20 minutes exposure of to UVA and UVB every day, which causes psoriasis, inflammation, and hyperpigmentation side effects in patients. While in this study UVA and UVB exposure is avoided and the results are obtained. No psoriasis, inflammation, or hyperpigmentation was seen in the subject during the study.

This study is an Endeavour to take potent seed extract and seed oil of Psoralea carlifolia Linn. (described in Drayvagun ІІ by Acharya Priyavatt Sharma) for the treatment of vitiligo, which can be the most trusted and least harmful treatment for vitiligo, nullifying all the side effects of chemical drugs available and cheaper than the treatments available.

Source of Funding

None.

Conflict of Interest

The authors declare no conflict of interest.

References

1 

JP Ortonne SK Bose Vitiligo: Where do we stand?Pigment Cell Res1993826172

2 

C Bergqvist K Ezzedine Vitiligo: A reviewDermatology2020236657192

3 

D Gupta R Kumari DM Thappa Depigmentation therapies in vitiligoIndian J Dermatol Venereol Leprol20127814958

4 

K Ongenae N Van Geel JM Naeyaert Evidence for an autoimmune pathogenesis of vitiligoPigment Cell Res20032290100

5 

N Elbuluk K Ezzedine Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo PatientsDermatol Clin201735211728

6 

JH Wu BA Cohen The stigma of skin diseaseCurr Opin Pediatr201931450914

7 

VJ Hearing Biochemical control of melanogenesis and melanosomal organizationJ Investig Dermatol Symp Proc199941248

8 

BA Gilchrest Effect of aging and chronic sunexposure on melanocytes in human skinJ Invest Dermatol19797321413

9 

ML Cucchi P Frattini G Santagostino S Preda G Orecchia Catecholamines increase in the urine of non segmental vitiligo especially during its active phasePigment Cell Res20031621116

10 

KU Schallreuter JM Wood I Ziegler KR Lemke MR Pittelkow NJ Lindsey Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligoBiochim Biophys Acta19941226218192

11 

A Krishnamurthi The Wealth of India: Raw Materials1969VII2958

12 

ADB Vaidya Reverse Pharmacological correlates of Ayurvedic drug actionsIndian J Pharmacol20063853115

13 

S Passi M Grandinetti F Maggio N Lowe Epidermal oxidative stress in vitiligoPigment Cell Res1998112815

14 

M Benathan V Virador M Furumura N Kobyashi RG Panizzon VJ Hearing Co-regulation of melanin precursors and tyrosinase in human pigment cells: role of cysteine and glutathioneCell Mol Biol (Noisy-le-grand)199945798190

15 

I Goth P Rass A Pay Catalase enzyme mutation and their association with diseaseMol Diagn2004831419

16 

MD Njoo PI Spuls JD Bos W Westerhof PM Bossuyt Nonsurgical repigmentation therapies in vitiligo: Meta-analysis of the literatureArch Dermatol199813412153240

17 

DB Mosher TB Fitzpatrick Y Hori JP Ortonne TB Fitzpatrick Disorders of melanocytesDermatology in general medicine4th edMcGraw-HillNew York199390395

18 

M Alkoy VK Celik S Ozelik M Polat M Marufihah A Atlay The effects of vitamin E on the skin lipid per-oxidation and the clinical improvement in vitiligo patients treated with PUVAEur J Dermatol2002121246



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

169-176


Authors Details

Anupama Sharma, Girish Chandra Sharma*


Article History

Received : 10-05-2022

Accepted : 19-05-2022


Article Metrics


View Article As

 


Downlaod Files